About Cure
Cure is a private company based in New York, New York. It has reported $8,783,103 raised in seven offerings on Form D since August 2018. Its chief executive is Lauren Picasso.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 9, 2024 | Sep 25, 2024 | $1,500,000of $3.0M target | 1 | $1.5M | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 11, 2023 | Aug 25, 2023 | $365,000of $2.0M target | 4 | $91,250 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 15, 2022 | Aug 30, 2022 | $3,000,000of $4.0M target | 25 | $120K | EquityRule 506(b) | Form D ↗ |
| Jan 15, 2021 | Feb 1, 2021 | $1,005,000of $2.0M target | 6 | $167K | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 5, 2020 | Aug 18, 2020 | $2,608,103fully sold | 33 | $79,033 | EquityRule 506(b) | Form D ↗ |
| Jul 1, 2019 | Jul 16, 2019 | $25,000of $1.0M target | 1 | $25,000 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 9, 2018 | Aug 28, 2018 | $280,000of $500K target | 12 | $23,333 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, seven offerings | $8,783,103 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cure's Form D filed Sep 25, 2024.
LP
Lauren Picasso
CEO and President, director